Sign up to our newsletter

Request a Prospectus



£325994.23 is the possible missed income that our Data Quality Assessment visits have found since the 1st August 2010. You may be missing out - book yours now.
Contact us for information
Company
latest news and events
WELCOME
to Insight Solutions

08/09/2010 Data - and how to get what you need With GP commissioning now centre stage, good quality data is more important than ever.

read more

Latest

08/09/2010 PAN Flu Guidance DES This document provides PCTs and general practices with updated information to help support the implementation of the DES

read more

Latest

07/09/2010 The Anaphylaxis Campaign: Basic information to medical staff about severe allergic reactions, their diagnosis and treatment.

read more

Latest

06/09/2010 GP commissioning DES could be extended across UK: GP commissioning could extend to Scotland, Wales and Northern Ireland if it is delivered as an enhanced service, according to GPC Wales.

read more

Latest

06/09/2010 Commissioning- Ten tips for GP leaders: Professor David Haslam has some timely advice for GPs who take on lead roles for commissioning care.

read more

Latest

03/09/2010 GP referrals on the rise again, DH figures show GP referrals to secondary care appear to be accelerating again, with the latest figures from the DOH showing a 6% year-on-year raise.

read more

Latest

03/09/2010 Small GP Consortia must share risk The size of consortia will not be important as long as risk is shared among neighbouring groups, a new GP commissioning council has conclude

read more

Latest

02/09/2010 Practice size 'makes no difference' to QOF achievement: The quality of care provided in small and single-handed practices is comparable to that provided by larger practices.

read more

Latest

27/08/2010 GP Leaders Issue Commissioning Guidance GPs must not profit personally from commissioning and their patients must remain their first responsibility.That is the key message.

read more

Latest

27/08/2010 AF drug cleared for use in final NICE guidance Atrial fibrillation (AF) drug dronedarone has been recommended by NICE for limited second-line use in final guidance issued this week.

read more

LatestShow More News Items

 Follow Insight Solutions on Twitter Copyright 2010 © - Insight Solutions IT Services Ltd Follow Insight Solutions on Twitter 
All rights Reserved (privacy | terms | delivery | cancellation | contact us)